Expression of Med19 in bladder cancer tissues and its role on bladder cancer cell growth (Q39561662)

13 September 2017

title

Expression of Med19 in bladder cancer tissues and its role on bladder cancer cell growth (English)

1 reference

13 September 2017

1 reference

1 reference

Hu Zhang

1

1 reference

13 September 2017

Haowen Jiang

2

1 reference

13 September 2017

Wei Wang

3

1 reference

13 September 2017

Jian Gong

4

1 reference

13 September 2017

Limin Zhang

5

1 reference

13 September 2017

Zhongqing Chen

6

1 reference

13 September 2017

Qiang Ding

7

1 reference

13 September 2017

publication date

7 April 2011

1 reference

13 September 2017

1 reference

13 September 2017

volume

30

1 reference

13 September 2017

issue

6

1 reference

13 September 2017

page(s)

920-927

1 reference

RNA interference against viruses: strike and counterstrike

13 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.10.003

The promises and pitfalls of RNA-interference-based therapeutics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.10.003

The ROX3 gene encodes an essential nuclear protein involved in CYC7 gene expression in Saccharomyces cerevisiae

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.10.003

Identification of Rox3 as a component of mediator and RNA polymerase II holoenzyme

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.10.003

Evidence for a mediator of RNA polymerase II transcriptional regulation conserved from yeast to man

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.10.003

Structure of eukaryotic Mediator complexes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.10.003

The structural and functional role of Med5 in the yeast Mediator tail module

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.10.003

A functional module of yeast mediator that governs the dynamic range of heat-shock gene expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.10.003

Med19(Rox3) regulates Intermodule interactions in the Saccharomyces cerevisiae mediator complex.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.10.003

MED19 and MED26 are synergistic functional targets of the RE1 silencing transcription factor in epigenetic silencing of neuronal gene expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.10.003

Expression of small hairpin RNA by lentivirus-based vector confers efficient and stable gene-suppression of HIV-1 on human cells including primary non-dividing cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.10.003

A lentivirus-based system to functionally silence genes in primary mammalian cells, stem cells and transgenic mice by RNA interference

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.10.003

Enhanced proliferation of cultured human vascular smooth muscle cells linked to increased function of RNA-binding protein HuR

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.10.003

Importin 7 may be dispensable for human immunodeficiency virus type 1 and simian immunodeficiency virus infection of primary macrophages

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.10.003

A high-titer lentiviral production system mediates efficient transduction of differentiated cells including beating cardiac myocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.10.003

A transient three-plasmid expression system for the production of high titer retroviral vectors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.10.003

Production and purification of lentiviral vectors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.10.003

Relative expression software tool (REST©) for group-wise comparison and statistical analysis of relative expression results in real-time PCR

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.10.003

siRNA-mediated gene silencing in vitro and in vivo.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.10.003

Stable suppression of tumorigenicity by virus-mediated RNA interference

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.10.003

Inhibiting HIV-1 infection in human T cells by lentiviral-mediated delivery of small interfering RNA against CCR5.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.10.003

Silencing of HIV-1 with RNA interference: a multiple shRNA approach

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.10.003

Lentiviral delivery of short hairpin RNAs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.10.003

A phase I/II clinical trial of beta-globin gene therapy for beta-thalassemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.10.003

Regulatory considerations for novel gene therapy products: a review of the process leading to the first clinical lentiviral vector

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2010.10.003

10.1016/J.UROLONC.2010.10.003

7 January 2021

Identifiers

DOI

1 reference

13 September 2017

1 reference